Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Diseases caused by bacterial infection have resulted in serious harm to human health. It is crucial to develop a multifunctional antibiotic-independent antibacterial platform for combating drug-resistant bacteria. Herein, titanium diboride (TiB) nanosheets integrated with quaternized chitosan (QCS) and indocyanine green (ICG) were successfully prepared as a synergetic photothermal/photodynamic antibacterial nanoplatform (TiB-QCS-ICG). The TiB-QCS-ICG nanocomposites exhibit effective photothermal conversion efficiency (24.92%) and excellent singlet oxygen (O) production capacity simultaneously under 808 nm near-infrared irradiation. QCS improved TiB stability and dispersion, while also enhancing adhesion to bacteria and further accelerating the destruction of bacteria by heat and O. experiments indicated that TiB-QCS-ICG had excellent antibacterial properties with an inhibition rate of 99.99% against () and methicillin-resistant (MRSA), respectively. More importantly, studies revealed that the nanoplatform can effectively inhibit bacterial infection and accelerate wound healing. The effective wound healing rate in the TiB-QCS-ICG treatment group was 99.6% which was much higher than control groups. Taken together, the as-developed TiB-QCS-ICG nanocomposite provides more possibilities to develop metal borides for antibacterial infection applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsabm.3c00290 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!